NCT03223935 is a NA clinical trial of Corn nuts in Normal Weight, sponsored by University of Manitoba.

Who is sponsoring NCT03223935?

NCT03223935 is sponsored by University of Manitoba.

What drugs are being tested in NCT03223935?

Interventions in NCT03223935: Corn nuts, Chickpeas, Yellow peas, Pinto beans, Soybeans, Almonds.

What condition does NCT03223935 study?

NCT03223935 studies Normal Weight, Overweight, Normoglycemic.

Is NCT03223935 still recruiting?

NCT03223935 is currently completed. Last updated 23 January 2023.

Last reviewed 2023-01-23 · How we verify

NCT03223935

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Roasted Pulse Snacks, Post-prandial Food Intake, Appetite, and Glycemia

Completed NA Last updated 23 January 2023

What this trial tests

NA trial testing Corn nuts in Normal Weight in 32 participants. Completed in 4 April 2018.

Timeline

11 August 2017

Primary endpoint
4 April 2018

4 April 2018

Quick facts

Lead sponsor	University of Manitoba
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	32
Start date	11 August 2017
Primary completion	4 April 2018
Estimated completion	4 April 2018
Sites	1 location across Canada

Drugs / interventions tested

Corn nuts
Chickpeas
Yellow peas
Pinto beans
Soybeans
Almonds

Conditions studied

Normal Weight — all drugs for Normal Weight →
Overweight — all drugs for Overweight →
Normoglycemic — all drugs for Normoglycemic →

Sponsor

University of Manitoba

Who can join

Adults 18 to 45, any sex, with Normal Weight or Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An investigation on the effects of roasted pulse snacks on post-prandial glycemic and satiety response in healthy young adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Normal Weight

Currently open trials in the same condition.

NCT06752967 — Hormonal Control of Energy and Macronutrient Intake in Obesity (MEMORY) · NA · recruiting
NCT06487832 — Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness · NA · recruiting
NCT04149288 — Olive Oil Polyphenols and Cardiovascular Health Biomarkers · NA · active not recruiting

Other University of Manitoba trials

Trials by the same sponsor.

NCT07528417 — Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) · Phase 2 · not yet recruiting
NCT07366515 — Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients · NA · not yet recruiting
NCT07354386 — Effects of Dried Whole Fruits on Metabolism in Diabetes · NA · enrolling by invitation
NCT07361315 — Development and Online Evaluation of an Online Course for Parasomnias · NA · recruiting
NCT07023744 — CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03223935 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Manitoba
Last refreshed: 23 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03223935.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing